Armata Pharmaceuticals Inc share price logo

Armata Pharmaceuticals Inc Share Price

NYSE: ARMP

Small Cap

$8.28

-0.01

(-0.12%)

as on

Armata Pharmaceuticals Inc Stock Performance

as on March 21, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $7.52
    $8.41
    downward going graph

    9.18%

    Downside

    1.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.90
    $16.34
    downward going graph

    89.15%

    Downside

    97.34%

    Upside

    downward going graph

Armata Pharmaceuticals Inc share price movements today

Previous Close
$8.29
Open
$7.84
Volume
184.8K
Day's Low - High
$7.52 - $8.41
52 Week Low - High
$0.90 - $16.34

Armata Pharmaceuticals Inc Historical Returns

1 Month Return
-12.05 %
3 Month Return
+ 33.6 %
1 Year Return
+ 368.72 %
3 Year Return
+ 441.29 %
5 Year Return
+ 59.2 %

Armata Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Armata Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$305.5M

EPS (TTM)

-1.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-31.9M

Revenue (TTM)

5.1M

Profit Margin

0.00%

Return On Equity TTM

-3439.35%

Armata Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Armata Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Armata Pharmaceuticals Inc image
Armata Pharmaceuticals Inc
BUY$305.5M59.2%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Armata Pharmaceuticals Inc Stock including INR - Dollar returns

The Armata Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Armata Pharmaceuticals Inc investment value today

Current value as on today

₹4,72,015

Returns

₹3,72,015

(+372.01%)

Returns from Armata Pharmaceuticals Inc Stock

₹3,62,570 (+362.57%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Armata Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Armata Pharmaceuticals Inc. Average target price of $15

Armata Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Armata Pharmaceuticals Inc.

What analysts predicted

44.8%UPSIDE

Target Price

$15

Current Price

$8.28

Analyzed by

8 Analysts

Target

$15.00

Armata Pharmaceuticals Inc target price $15, a slight upside of 44.8% compared to current price of $8.28. According to 8 analysts rating.

Armata Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Armata Pharmaceuticals Inc Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:54% versus previous 30 day period

Armata Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
1
1
0
-
2
1
0
2
1
Gross Profit
0
1
1
0
0
2
0
0
1
0
Operating Income
-9
-10
-9
-10
-11
-9
-10
-8
-6
-7
EBITDA
-3
-29
-18
-22
12
-2
6
-2
-12
-21
Interest Expense
-
1
1
1
2
2
3
3
3
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-31
-19
-25
8
-5
2
-6
-16
-26
Income Tax Expense
-6
-14
17
0
-
-
0
-
-
-
Net Income
-3
-31
-19
-25
8
-5
2
-6
-16
-26
Net Profit Margin
-361.94%
-2543.76%
-1298.89%
-2590.17%
0.00%
-184.36%
210.53%
-1330.14%
-751.27%
-2301.55%

Armata Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
-
0
0
4
5
4
5
Gross Profit
0
0
0
-1
-1
-13
-15
-29
3
-29
Operating Income
-10
-23
-16
-12
-19
-21
-23
-36
-40
-42
EBITDA
-10
-13
-9
-9
-17
-20
-21
-36
-65
-41
Interest Expense
-
-
-
-
0
0
0
0
2
10
Depreciation
-
-
0
0
1
1
1
0
0
1
Income Before Tax
0
-19
-14
-16
-19
-22
-23
-36
-69
-18
Income Tax Expense
0
0
-1
0
0
0
0
0
-
-
Net Income
0
-18
-12
-12
-19
-22
-23
-36
-69
-18
Net Profit Margin
-108.63%
-7245.38%
-11163.48%
0.00%
-62835.48%
-2695.14%
-517.55%
-670.24%
-1524.51%
-365.60%

Armata Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-31
-19
-25
8
-5
2
-6
-16
-26
Operating Cash Flow
-9
-8
-10
-10
-8
-7
-7
-7
-4
Investing Cash Flow
-3
-2
0
-1
0
0
0
0
0
Financing Cash Flow
24
0
34
0
0
-
9
-
14
Change in Cash
11
-10
24
-11
-9
-7
2
-7
10

Armata Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-18
-12
-12
-19
-22
-23
-36
-69
-18
Operating Cash Flow
-10
-9
-9
-15
-18
-23
-32
-47
-37
Investing Cash Flow
0
0
0
2
0
-1
-2
-8
-1
Financing Cash Flow
7
8
12
8
23
25
44
53
34
Change in Cash
-3
0
3
-3
4
0
4
-1
-4

Insights on Armata Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ARMP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ARMP has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ARMP stock has moved down by -13.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 2.6M → -26.67M (in $), with an average decrease of 188.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.16M → 1.15M (in $), with an average decrease of 46.6% per quarter

About Armata Pharmaceuticals Inc

c3 jian is a well-capitalized, private, los angeles based biotechnology company advancing novel compounds that target unmet medical/dental needs related primarily to oral healthcare. the company's lead compound is a unique peptide drug against dental caries (i.e. tooth decay). the company’s lead compound started fda-regulated phase ii human clinical trials in early 2014. c3 jian's platform technology has also yielded peptides that can affect calcification processes, including not only tooth sensitivity but possibly hair and nail growth as well. the company has recently moved its operations to a new facility in marina del rey. the company was founded based on technology created in the laboratory of dr. wenyuan shi, chair of the department of oral biology at the university of california, los angeles school of dentistry. for more information about the company and to explore career opportunities at c3 jian please visit our webpage at www.c3-jian.com
OrganisationArmata Pharmaceuticals Inc
Headquarters5005 McConnell Avenue, Los Angeles, CA, United States, 90066
IndustryBiotechnology
CEODr. Deborah L. Birx M.D.
E-voting on sharesClick here to vote

Key Management of Armata Pharmaceuticals Inc

Name

Title

Dr. Deborah L. Birx M.D.

CEO & Director

Mr. David D. House

Senior VP of Finance & Principal Financial Officer

Dr. Pierre Kyme Ph.D.

Chief Business Officer

Mr. Peter Hubbard

Vice President of Operations

Ms. Bani Tchekanova Ph.D.

Head of Regulatory Strategy & Operations

FAQs

What is Armata Pharmaceuticals Inc share price today?

Armata Pharmaceuticals Inc share price today is $8.28 as on at the close of the market. Armata Pharmaceuticals Inc share today touched a day high of $8.41 and a low of $7.52.

What is the 52 week high and 52 week low for Armata Pharmaceuticals Inc share?

Armata Pharmaceuticals Inc share touched a 52 week high of $16.34 on and a 52 week low of $0.9 on . Armata Pharmaceuticals Inc stock price today i.e. is closed at $8.28,which is 49.33% down from its 52 week high and 821.95% up from its 52 week low.

What is Armata Pharmaceuticals Inc's market capitalisation today?

Armata Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Armata Pharmaceuticals Inc Stock (ARMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Armata Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Armata Pharmaceuticals Inc Shares that will get you 0.1812 shares as per Armata Pharmaceuticals Inc share price of $8.28 per share as on March 21, 2026 at 1:28 am IST.

What is the minimum amount required to buy Armata Pharmaceuticals Inc Stock (ARMP) from India?

Indian investors can start investing in Armata Pharmaceuticals Inc (ARMP) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Armata Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Armata Pharmaceuticals Inc share’s latest price of $8.28 as on March 21, 2026 at 1:28 am IST, you will get 1.2077 shares of Armata Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Armata Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Armata Pharmaceuticals Inc stock has given 59.2% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?